More than 1.5 billion people, nearly 20% of the global population, currently live with hearing loss, yet worldwide hearing aid production meets less than 10% of demand (WHO, Deafness and Hearing Loss Fact Sheet 2025). Of those, 430 million have disabling hearing loss, and the World Health Organization projects the total will climb to 2.5 billion, 1 in 4 people, by 2050. In the United States, about 28.8 million adults could benefit from a hearing aid, but only roughly 16% of adults aged 20 to 69 who could benefit have ever used one (NIDCD, Quick Statistics About Hearing 2024). Unaddressed hearing loss carries an annual global cost of almost US$1 trillion. This analysis consolidates data from the World Health Organization, the US National Institute on Deafness and Other Communication Disorders (NIDCD), the MarkeTrak 2025 survey, Grand View Research, MarketsandMarkets, and 15 other primary sources.
TL;DR
- More than 1.5 billion people live with hearing loss worldwide; 430 million have disabling hearing loss (WHO, Fact Sheet 2025).
- By 2050, 2.5 billion people, or 1 in 4, are projected to have some degree of hearing loss (WHO, World Report on Hearing 2021).
- 28.8 million US adults could benefit from hearing aids, but only about 16% of those aged 20 to 69 have used them (NIDCD, 2024).
- Overall US hearing aid adoption reached 39% in 2025, up from 30% in 2015 and 23% in 1989 (MarkeTrak 2025).
- OTC devices accounted for 5.7% of adoption, and 70% of OTC buyers were first-time users (MarkeTrak 2025).
- The average price of a pair fell 42% to 2,694 dollars between 2018 and late 2025 (HearingTracker 2026).
- The global hearing aids market was valued at 9.1 billion dollars in 2025, forecast to 17.9 billion by 2035 (Grand View Research 2025).
- Five manufacturers control roughly 90% of the global hearing aid market (Economic Liberties 2025).
- Hearing loss is tied for the largest modifiable dementia risk factor, linked to about 7% of cases (Lancet Commission 2024).
- Adults with hearing loss delay seeking help for an average of about 8.9 years (ASHA).
- 28% of US workers have been exposed to hazardous noise, and 53% of noise-exposed workers do not wear hearing protection (CDC NIOSH).
1. Global Hearing Loss Prevalence and Burden
Hearing loss is one of the most widespread chronic conditions on the planet, and the supply of devices has not kept pace with need. The WHO frames the shortfall bluntly: worldwide hearing aid production currently meets less than 10% of global demand. The projected doubling of cases by mid-century is driven largely by population aging and preventable causes such as untreated infections and noise exposure. Full figures are in the WHO Deafness and Hearing Loss Fact Sheet and the WHO World Report on Hearing.
| Metric | Value | Source |
|---|---|---|
| People living with hearing loss worldwide | 1.5 billion (nearly 20% of population) | WHO, Deafness and Hearing Loss Fact Sheet 2025 |
| People with disabling hearing loss | 430 million | WHO, Fact Sheet 2025 |
| Projected with hearing loss by 2050 | 2.5 billion (1 in 4) | WHO, World Report on Hearing 2021 |
| Projected disabling hearing loss by 2050 | 700 million+ (1 in 10) | WHO, Fact Sheet 2025 |
| Share of global hearing aid demand met by production | Less than 10% | WHO, Fact Sheet 2025 |
| Annual global cost of unaddressed hearing loss | ~US$1 trillion | WHO, Fact Sheet 2025 |
| Children with disabling hearing loss | 34 million | WHO, Fact Sheet 2025 |
Context: WHO estimates governments see a return of nearly US$16 for every US$1 invested in ear and hearing care, and that almost 60% of childhood hearing loss is preventable (WHO, World Report on Hearing 2021). For related environmental drivers, see our noise pollution statistics.
2. The US Adoption Gap: Who Needs Hearing Aids vs Who Uses Them
The defining US statistic is not prevalence but the gap between need and use. Only about 1 in 6 adults aged 20 to 69 who could benefit from a hearing aid has ever used one. The gap narrows with age, because hearing loss becomes both more common and more severe, but a majority of older adults with disabling loss still go without. The NIDCD Quick Statistics About Hearing is the standard reference.
| Metric | Value | Source |
|---|---|---|
| US adults who could benefit from hearing aids | 28.8 million | NIDCD, Quick Statistics About Hearing 2024 |
| Adults 20-69 with hearing loss | 14% (27.7 million) | NIDCD, 2024 |
| Adults 20-69 who could benefit and have used a hearing aid | ~16% | NIDCD, 2024 |
| Adults 70+ who have ever used a hearing aid | Fewer than 30% | NIDCD, 2024 |
| Disabling hearing loss, ages 65-74 | 22% | NIDCD, 2024 |
| Disabling hearing loss, ages 75+ | 55% | NIDCD, 2024 |
| Americans reporting tinnitus in the past year | ~25 million (10%) | NIDCD, 2024 |
Outlier: Men are almost twice as likely as women to have hearing loss among adults aged 20 to 69, and disabling loss rises from about 5% at ages 45 to 54 to 10% at ages 55 to 64 (NIDCD, 2024).
3. Adoption Trends and the OTC and Hearables Era
Adoption is finally moving after decades of stagnation, and the 2022 FDA over-the-counter category is a major reason. Overall hearing aid adoption reached 39% in 2025, up from 30% a decade earlier. OTC devices are pulling in a younger, first-time audience that traditional clinics rarely reached, while consumer earbuds with hearing-improvement features have become a parallel on-ramp. See the MarkeTrak 2025 survey analysis and the FDA authorization of the first OTC hearing aid software.
| Metric | Value | Source |
|---|---|---|
| Overall adoption rate 2025 (23% in 1989) | 39% | MarkeTrak 2025 |
| Traditional hearing aid adoption | 33.5% | MarkeTrak 2025 |
| OTC hearing aid adoption | 5.7% | MarkeTrak 2025 |
| Report using earbuds with a hearing-improvement feature | 20.9% | MarkeTrak 2025 |
| OTC buyers who are first-time users (vs 58% traditional) | 70% | MarkeTrak 2025 |
| Median age, OTC vs traditional users | 58 vs 73 | MarkeTrak 2025 |
| FDA OTC hearing aid software clinical study subjects | 118 | FDA, 2024 |
| Apple AirPods Pro 2 hearing aid price point | ~US$250 | Mordor Intelligence, Hearables Market 2026 |
Context: Satisfaction ran 83% for traditional aid owners versus 76% for OTC owners, and the FDA study found self-fitting matched professional fitting on amplification and speech-in-noise measures (MarkeTrak 2025; FDA, 2024). The blurring line between earbuds and medical devices is covered in our wireless earbuds statistics.
4. Market Size, Growth, and the Big Five
The hearing aid business is large, growing steadily, and unusually concentrated. The Big Five manufacturers control roughly 90% of the global hearing aid market. Growth estimates diverge by firm but cluster around a mid-single-digit to 7% CAGR, driven by aging populations and digital device penetration. Compare Grand View Research with the MarketsandMarkets forecast.
| Metric | Value | Source |
|---|---|---|
| Global hearing aids market 2025 | US$9.1 billion | Grand View Research, 2025 |
| Global market forecast 2035 (7.0% CAGR) | US$17.9 billion | Grand View Research, 2025 |
| Global market, alternate estimate (6.8% CAGR) | US$9.74B (2024) to US$14.42B (2030) | MarketsandMarkets, 2025 |
| US hearing aids market by 2030 (5.7% CAGR) | US$3.01 billion | Grand View Research |
| Europe share of global market 2025 | 39.7% | Grand View Research, 2025 |
| Global units sold by EHIMA members 2024 | 22.69 million (+4%) | EHIMA, 2025 |
| US units sold 2024 (HIA members) | 2,245,540 (+4%) | HIA, 2024 |
| Big Five share of global market | ~90% | Economic Liberties, 2025 |
Divergence: Grand View and MarketsandMarkets disagree by roughly 3.5 billion dollars on 2030 market value, reflecting different scope and OTC treatment. Receiver-in-the-ear devices held 62.6% of the market and digital technology 93.3% in 2025 (Grand View Research, 2025).
5. What Hearing Aids Cost and Who Pays
Price is the single most cited barrier, and it is finally falling as buyers move out of bundled clinic channels. The average price of a pair fell 42% to 2,694 dollars between 2018 and late 2025. The spread is enormous: a premium clinic pair can top 5,000 dollars while a basic OTC pair sells for a few hundred. Detailed channel pricing is tracked by HearingTracker.
| Metric | Value | Source |
|---|---|---|
| Traditional clinic pair, no insurance, late 2025 | ~US$4,727 | HearingTracker, 2026 |
| Average price per pair, late 2025 (down 42% since 2018) | US$2,694 | HearingTracker, 2026 |
| Costco average per pair | ~US$1,674 | HearingTracker, 2026 |
| OTC average per pair | ~US$502 | HearingTracker, 2026 |
| MarkeTrak traditional aid median price (per device) | US$1,560 | MarkeTrak 2025 |
| MarkeTrak OTC median price (per device) | US$150 | MarkeTrak 2025 |
| Hearing aid owners with insurance coverage, 2025 vs 2015 | 63% vs 48% | MarkeTrak 2025 |
Context: Original Medicare excludes hearing aids and fitting exams entirely, though 88% of Medicare Advantage plans offer some coverage (Center for Medicare Advocacy). The US OTC segment alone was valued near US$351.7 million in 2023, forecast to US$560.2 million by 2030 (Grand View Research).
6. Health Impact: Dementia, Delay, and Occupational Noise
Untreated hearing loss is no longer framed as a lifestyle inconvenience but as a public-health risk with downstream costs. Hearing loss is tied for the single largest modifiable risk factor for dementia, linked to about 7% of cases worldwide. Meanwhile, occupational noise keeps generating preventable damage, and adults still wait years before acting. This is informational, not medical advice; anyone concerned about their hearing should consult a licensed audiologist or physician. See the 2024 Lancet Commission update on hearing and dementia and CDC NIOSH noise surveillance.
| Metric | Value | Source |
|---|---|---|
| Dementia cases attributable to hearing loss | ~7% | Lancet Commission, 2024 |
| Dementia potentially preventable via 14 modifiable factors | Up to 45% | Lancet Commission, 2024 |
| Average delay before adults seek help | ~8.9 years | ASHA |
| US workers ever exposed to hazardous noise | 28% | CDC NIOSH |
| Workers exposed to hazardous noise in the past year | 16% (27 million) | CDC NIOSH |
| Noise-exposed workers with hearing difficulty (vs 7% non-exposed) | 23% | CDC NIOSH |
| Noise-exposed workers not wearing hearing protection | 53% | CDC NIOSH |
| Children and adolescents under 20 with any hearing loss, 2021 | 97.83 million | GBD Study, 2021 |
Note: The 34 million children figure in Section 1 counts disabling loss specifically, while the 97.83 million GBD figure counts any hearing loss under age 20, so the two are not contradictory. Only about 20% of people who could benefit from treatment seek help, and 8% of all US workers have tinnitus (ASHA; CDC NIOSH). For preventive audio technology context, see our AI noise reduction guide.
Summary: Hearing Aids by the Numbers
| Metric | Value | Source |
|---|---|---|
| People with hearing loss worldwide | 1.5 billion (~20%) | WHO, Fact Sheet 2025 |
| People with disabling hearing loss | 430 million | WHO, Fact Sheet 2025 |
| Projected hearing loss by 2050 | 2.5 billion (1 in 4) | WHO, World Report on Hearing 2021 |
| Global hearing aid demand met by production | Less than 10% | WHO, Fact Sheet 2025 |
| Annual global cost of unaddressed hearing loss | ~US$1 trillion | WHO, Fact Sheet 2025 |
| US adults who could benefit from hearing aids | 28.8 million | NIDCD, 2024 |
| Adults 20-69 who could benefit and used one | ~16% | NIDCD, 2024 |
| Disabling hearing loss, ages 75+ | 55% | NIDCD, 2024 |
| Overall US adoption rate 2025 | 39% | MarkeTrak 2025 |
| OTC hearing aid adoption | 5.7% | MarkeTrak 2025 |
| OTC buyers who are first-time users | 70% | MarkeTrak 2025 |
| Traditional vs OTC owner satisfaction | 83% vs 76% | MarkeTrak 2025 |
| Average price per pair, late 2025 | US$2,694 (down 42% since 2018) | HearingTracker, 2026 |
| OTC average price per pair | ~US$502 | HearingTracker, 2026 |
| Global hearing aids market 2025 | US$9.1 billion | Grand View Research, 2025 |
| Global market forecast 2030 (alt.) | US$14.42 billion | MarketsandMarkets, 2025 |
| Big Five share of global market | ~90% | Economic Liberties, 2025 |
| Dementia cases attributable to hearing loss | ~7% | Lancet Commission, 2024 |
| Average delay before seeking help | ~8.9 years | ASHA |
| US workers ever exposed to hazardous noise | 28% | CDC NIOSH |
Methodology and Sources
Data was gathered by aggregating figures from primary reports, government datasets, peer-reviewed studies, and named industry-association surveys published mainly in 2024 to 2026, cross-referencing market-size estimates across multiple firms and flagging divergences.
- World Health Organization, Deafness and Hearing Loss Fact Sheet (2025) and World Report on Hearing (2021)
- US National Institute on Deafness and Other Communication Disorders (NIDCD), Quick Statistics About Hearing (2024)
- MarkeTrak 2025 survey, Hearing Industries Association (published 2025); MarkeTrak 2022 satisfaction results (PMC)
- US Food and Drug Administration, FDA Authorizes First Over-the-Counter Hearing Aid Software (2024)
- Grand View Research, Hearing Aids Market and OTC Hearing Aids Market reports (2025)
- MarketsandMarkets, Hearing Aids Market (2025)
- European Hearing Instrument Manufacturers Association (EHIMA), 2024 sales report; Hearing Industries Association (HIA) US unit data (2024)
- HearingTracker, How Much Do Hearing Aids Cost (2026)
- Lancet Commission on dementia prevention, intervention, and care (2024 update)
- CDC NIOSH, Occupational Noise and Hearing Loss Surveillance
- American Speech-Language-Hearing Association (ASHA), Untreated Hearing Loss in Adults
- Global Burden of Disease Study 2021, hearing loss in children and adolescents (BMC Public Health / PMC)
- Mordor Intelligence, Hearables Market (2026); Economic Liberties, hearing aid market concentration report (2025); Center for Medicare Advocacy, hearing coverage guidance
Data watch: MarkeTrak surveys the US market on a multi-year cycle, so the 2025 edition is the current benchmark; EHIMA and HIA publish annual unit-sales updates each spring; WHO refreshes guidance around World Hearing Day every March; Grand View Research and MarketsandMarkets reissue market forecasts annually; the Lancet Commission updates its dementia risk model periodically. Related VoxBooster analyses include our hearing loss and headphone statistics.
Last updated: July 5, 2026.
We review and update this page quarterly as new data is published.